Prader–Willi Syndrome (PWS) is an imprinting disorder caused by a deficiency of paternally expressed genes along a specific region of chromosome 15 (15q11–q13) and is characterized by neonatal ...
REDWOOD CITY, Calif. - Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company with a market capitalization of $3.08 billion, announced today the U.S. commercial availability of VYKAT XR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results